Recent headlines that Oxford University's Covid-19 vaccine might be ready as soon as September was followed less than 48 hours later by news that Oxford had signed an exclusive worldwide licensing deal with Astra Zeneca.
But the announcement of the deal mentioned nothing about plans for pricing or access of the new vaccine.
Once again, a large ...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? LoginRoxana Bonnell is a senior advisor at Open Society's Public Health Program, and was involved in creating OSF's Access to Medicines Initiative over 15 years ago.
Roxana Bonnell is a senior advisor at Open Society's Public Health Program, and was involved in creating OSF's Access to Medicines Initiative over 15 years ago.